Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed

• Ngā kaituhi matua: Guillaume Le Guyader (Author), Bernard Do (Author), Victoire Vieillard (Author), Karine Andrieux (Author), Muriel Paul (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2020-11-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Rapamycin has been used topically to treat facial angiofibromas associated with tuberous sclerosis for more than a decade. In the absence of a commercial form, a large number of formulations have been clinically tested. However, given the great heterogeneity of these studies, particularly with regar...